Safety and Efficacy of Low-Dose Prednisolone with Pirfenidone in Idiopathic Pulmonary Fibrosis

被引：0
|
作者：
Matsubayashi, S. [1 ]
Izumi, S. [1 ]
Takumida, H. [1 ]
Watanabe, H. [1 ]
Matsumoto, S. [1 ]
Kusaba, Y. [1 ]
Katsuno, T. [1 ]
Kakuwa, T. [1 ]
Tsujimoto, Y. [1 ]
Sakamoto, K. [1 ]
Hashimoto, M. [1 ]
Ishii, S. [1 ]
Morino, E. [1 ]
Suzuki, M. [1 ]
Takasaki, J. [1 ]
Naka, G. [1 ]
Iikura, M. [1 ]
Takeda, Y. [1 ]
Sugiyama, H. [1 ]
机构：
[1] Natl Ctr Global Hlth & Med, Resp Med, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4769
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
    Takeda, Yoshito
    Tsujino, Kazuyuki
    Kijima, Takashi
    Kumanogoh, Atsushi
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 361 - 370
  • [2] Efficacy and Safety of Pirfenidone in Idiopathic Pulmonary Fibrosis According to Dose and Disease Severity
    Park, J.
    Lee, J.
    Choi, S.
    Cho, J. Y.
    Lee, Y.
    Cho, Y.
    Yim, J.
    Lee, J.
    Lee, C.
    Kim, Y.
    Hwang, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosis
    Ntolios, Paschalis
    Koulelidis, Andreas
    Zacharis, Georgios
    Tzouvelekis, Argyrios
    Boglou, Panagiotis
    Kaltsas, Konstantinos
    Bouros, Evangelos
    Karampitsakos, Theodoros
    Karailidou, Maria
    Steiropoulos, Paschalis
    Froudarakis, Manes
    Bouros, Demosthenes
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [4] Efficacy and Safety of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis
    Yoon, Hee-Young
    Kim, Dong Soon
    Song, Jin Woo
    RESPIRATION, 2019, 97 (03) : 242 - 251
  • [5] Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice
    Okuda, Ryo
    Hagiwara, Eri
    Baba, Tomohisa
    Kitamura, Hideya
    Kato, Terufumi
    Ogura, Takashi
    RESPIRATORY MEDICINE, 2013, 107 (09) : 1431 - 1437
  • [6] Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
    Kondoh, Y
    Taniguchi, H
    Yokoi, T
    Nishiyama, O
    Ohishi, T
    Kato, T
    Suzuki, K
    Suzuki, R
    EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (03) : 528 - 533
  • [7] Treatment efficacy of idiopathic pulmonary fibrosis depending on the dose difference of pirfenidone
    Shin, Yuneyoung
    Lee, Choon-Taek
    Lee, Jae Ho
    Yoon, Ho Il
    Cho, Young-Jae
    Park, Jong Sun
    Lee, Yeon Joo
    Lim, Sung Yoon
    Lee, Yung Hee
    Choi, Sung Young
    Kim, Yeon Wook
    Kwon, Byoung Soo
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [8] Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis
    Marcos Ribes, Borja
    Sancho-Chust, Jose N.
    Talens, Amparo
    Arlandis, Mar
    Herraiz, Paola
    Chiner, Eusebi
    Aznar, Teresa
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (06) : 350 - 354
  • [9] EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Inagaki, Ai
    Tsutsumi, Takeo
    Kuriyama, Sachiko
    Nagaoka, Tetsutaro
    Sekiya, Mitsuaki
    Morio, Yoshiteru
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 135 - 135
  • [10] Predictors of efficacy of pirfenidone in idiopathic pulmonary fibrosis
    Kataoka, Kensuke
    Taniguchi, Hiroyuki
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Matsuda, Toshiaki
    Yokoyama, Toshiki
    Yamano, Yasuhiko
    Nakahara, Yoshio
    Yagi, Mitsuaki
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345